Trasis invites you to their event

Rethinking Sterility Testing in Radiopharmacy

About this event

Sterility testing remains one of the most critical, and constrained, steps in radiopharmaceutical production. Outsourcing, extended turnaround times, and stringent regulatory and pharmacopoeial requirements continue to challenge radiopharmaceutical production centers.

In this webinar, we revisit these challenges and introduce SteriNow®, a solution designed to support a compliant in-house approach to sterility testing.

SteriNow®, invented by CUP Contract Labs and designed and engineered by Trasis, integrated seamlessly within the Trasis technical ecosystem, with regulatory and pharmacopoeial constraints at its core.

The session offers a concise technical and regulatory perspective for production centers considering an internal evaluation of in-house sterility testing.

Co-hosted by Dirk Freitag-Stechl, PhD, Managing Director at CUP Contract Labs, and Thomas Vergote, PhD, Product Manager at Trasis, the webinar will conclude with a live Q&A session, allowing participants to ask questions directly to both speakers.

Hosted by

  • External speaker
    E
    Gwendolin Zeiske Scientific Associate @ CUP Contract Labs
  • External speaker
    E
    Dirk Freitag-Stechl CUP contract
  • Team member
    SK T
    Stéphanie Keydeners Marketing and communication coordinator @ Trasis

    Responsable MarCom

Trasis

Welcome to Trasis, your reliable partner in Radiopharmacy. At Trasis, we have an unwavering commitment to advancing nuclear medicine and radiopharmaceuticals technology to help improve health and wellbeing. Trasis was created in 2004 by professionals e...